Tirzepatide Injection Pen
video

Tirzepatide Injection Pen

Compatible Medications: Tirzepatide, GIP/GLP-1 receptor agonists
Primary Container: Standard 3.0 mL Cartridges (ISO 11608-3)
Dose Increment: 2.5 mg increments (customizable gearing)
Max Single Delivery: Up to 15 mg (0.6 mL per injection)
Operational Lifespan: Guaranteed 4,000+ clinical cycles
Safety Feature: Non-reversible dial with end-of-dose lock
Drive System: Low-friction linear plunger displacement
Send Inquiry

Description

Technical Parameters

Tirzepatide Injection Pen
Tirzepatide Injection Pen | Multi-Dose Precision Delivery System

The Tirzepatide Injection Pen is a sophisticated, reusable medical instrument engineered for the administration of dual-agonist therapies. Designed to accommodate the standard 4-week titration cycles of weight management and glycemic control medications, this platform offers exceptional dosing accuracy and mechanical reliability for B2B pharmaceutical partners.

We provide comprehensive OEM solutions for pharmaceutical manufacturers:

Custom Color Coding: Match the pen's exterior to specific dosage strengths (e.g., 2.5 mg vs 15 mg).

Private Labeling: High-resolution laser engraving for corporate branding.

Regulatory Support: Complete technical files available for local health authority registration.

Product Features

Tirzepatide Injection Pen
Tirzepatide Injection Pen
Tirzepatide Injection Pen
Tirzepatide Injection Pen

1. Optimized for Dose Escalation

Tirzepatide therapy requires strict adherence to a 2.5 mg, 5 mg, 7.5 mg, to 15 mg titration schedule. Our pen's internal gear ratio is specifically calibrated to handle these stepped increments, ensuring that B2B distributors can provide a single, consistent hardware platform for patients throughout their entire treatment journey.

2. Pharmaceutical-Grade Accuracy

Equipped with a zero-loss plunger interface, the pen ensures that the exact volume of high-value medication is delivered with every click. This precision is critical for GIP/GLP-1 therapies where slight over-dosing can lead to significant gastrointestinal side effects.

3. Sustainable Procurement Model

By utilizing a reusable metal-core chassis, healthcare providers can reduce their environmental footprint by up to 80% compared to disposable autoinjector programs. This refillable system simplifies cold-chain logistics, as only the lightweight medication cartridges require refrigeration, not the entire delivery device.

4. Advanced User Interface

Tactile Engagement: Distinct audible clicks provide sensory confirmation during dose selection.

Large Vision Window: Magnified dose numbers allow for easy verification, reducing clinical errors in self-administration.

Ergonomic Trigger: Specifically positioned for sub-cutaneous injection in the abdomen or thigh, requiring minimal thumb pressure.

 

Our Certificate

 

product-1654-2339
product-1654-2339
product-1687-2386
product-1653-2336
product-1643-2291

Company Partner

product-1683-538

OEM/ODM Service

product-1752-678

 

Quality Checking Process

product-3680-2456
product-3680-2456
product-3680-2456

Production Process

product-3680-2456
product-3680-2456
product-3680-2456
product-3680-2456
product-3680-2456
product-3680-2456
product-3680-2456
product-3680-2456

FAQ

Q1: How does this pen maintain accuracy across different Tirzepatide concentrations?

A: The mechanical drive is independent of concentration; it precisely controls the linear displacement (mL) of the cartridge stopper. This ensures that whether the cartridge contains 5mg/0.5mL or 15mg/0.5mL, the volumetric delivery remains constant and accurate.

Q2: Can the pen prevent a user from selecting a dose larger than what remains in the cartridge?

A: Yes. The device features a residual dose limiter. The dose knob will not turn past the remaining volume in the 3.0 mL cartridge, preventing "dry" or incomplete injections and ensuring patient safety.

Q3: What is the benefit of the threaded "screw-on" needle interface?

A: The threaded interface is the global standard for multi-dose safety needles. It provides a more secure, leak-proof connection than "push-on" alternatives, which is vital for maintaining the sterility and integrity of multi-week Tirzepatide therapy.

Q4: Is the pen's drive mechanism compatible with varying liquid viscosities?

A: The spring-assisted linear drive is engineered to provide a constant injection speed. This compensates for the slightly higher viscosity found in concentrated peptide solutions, ensuring the medication is absorbed evenly without manual resistance.

Q5: What are the storage requirements for the pen hardware?

A: Unlike pre-filled disposable pens, the reusable pen hardware can be stored at room temperature (15°C to 30°C). This reduces the burden on pharmacy cold-storage space, as only the medication cartridges need to be kept in the refrigerator.

Get A Quote Now!

Hot Tags: tirzepatide injection pen, China tirzepatide injection pen manufacturers, suppliers, factory, Disposable Pen Syringe, medical consumable, Reusable Pen Syringe

Specifications

Technical Variable Specification Details
Compatible Medications Tirzepatide, GIP/GLP-1 receptor agonists
Primary Container Standard 3.0 mL Cartridges (ISO 11608-3)
Dose Increment 2.5 mg increments (customizable gearing)
Max Single Delivery Up to 15 mg (0.6 mL per injection)
Operational Lifespan Guaranteed 4,000+ clinical cycles
Safety Feature Non-reversible dial with end-of-dose lock
Drive System Low-friction linear plunger displacement

 

 

Send Inquiry